British drug maker AstraZeneca PLC recently made an abortive acquisition approach to Forest Laboratories Inc before the specialtydrug company agreed last week to be bought by Actavis PLC for  billion according to people familiar with the matter Late last year AstraZeneca approached Forest about a deal for around  a share according to some of the people The cashandstock deal that Actavis sealed valued Forest at  a share